{
    "nct_id": "NCT04067960",
    "official_title": "Precision Pharmacogenomics in Cancer Patients",
    "inclusion_criteria": "* Patient enrolled to Mayo Clinic IRB: 18-000326\n* Patients with stage 3 or 4 breast, colorectal, prostate/genitourinary (GU), pancreato-biliary, brain, melanoma, and ovarian cancer\n* Individuals have agreed to participate and signed the study informed consent form\nHealthy volunteers allowed",
    "exclusion_criteria": "* Patients with cancer types other than the ones mentioned above\n* Patient with psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent\n* Previous PGx testing with results available within Mayo Clinic electronic medical record (EMR)",
    "miscellaneous_criteria": ""
}